<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>week 05 protein design part 2 :: 2026a-adriana-cabrera</title><link>https://pages.htgaa.org/2026a/adriana-cabrera/homework/week-05-hw-protein-design-part-ii/index.html</link><description>Still not really sure what I am doing :-)!
Basics
Design short peptides that bind mutant SOD1. “Design short peptides that bind mutant SOD1” means creating small, synthetic chains of amino acids (peptides) specifically engineered to attach to a deformed version of the Superoxide Dismutase 1 (SOD1) protein. This is a therapeutic strategy aimed at treating SOD1-related Amyotrophic Lateral Sclerosis (ALS).
Mutant SOD1: A faulty version of the SOD1 enzyme produced due to genetic mutations. Unlike healthy SOD1, mutant SOD1 misfolds, becomes unstable, and aggregates (clumps together), leading to toxicity in motor neurons.</description><generator>Hugo</generator><language>en</language><atom:link href="https://pages.htgaa.org/2026a/adriana-cabrera/homework/week-05-hw-protein-design-part-ii/index.xml" rel="self" type="application/rss+xml"/></channel></rss>